(Q36689023)

15 August 2017

1 reference

title

Live-attenuated Shigella vaccines (English)

1 reference

15 August 2017

1 reference

Malabi M Venkatesan

1

1 reference

PubMed ID

17181440

15 August 2017

Ryan T Ranallo

series ordinal

2

1 reference

15 August 2017

1 October 2006

1 reference

Expert Review of Vaccines

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

5

1 reference

15 August 2017

669-686

1 reference

High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Identification and characterization of Shigella boydii 20 serovar nov., a new and emerging Shigella serotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Bacterial invasion: the paradigms of enteroinvasive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Shigella flexneri infection: pathogenesis and vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

A review of vaccine research and development: human enteric infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Enteric infections and the vaccines to counter them: future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Shigella and Salmonella: death as a means of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

icsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Active immunity is seen as a reduction in the cell response to oral live vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Development of an auxotrophic oral live Shigella flexneri vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: Characterization and monkey protection studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Molecular characterization of the genes involved in O-antigen modification, attachment, integration and excision in Shigella flexneri bacteriophage SfV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Functional analysis of the O antigen glucosylation gene cluster of Shigella flexneri bacteriophage SfX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Developing live Shigella vaccines using lambda Red recombineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Houseflies (Musca domestica) as Mechanical Vectors of Shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

Pathogenesis and Immune Responses in Shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.669

21 January 2018

Identifiers

DOI

10.1586/14760584.5.5.669

1 reference

15 August 2017

1 reference

PubMed ID

17181440